Lim CS - Search Results

1

Solid phase synthesis of mitochondrial triphenylphosphonium-vitamin E metabolite using a lysine linker for reversal of oxidative stress.

Mossalam M, Soto J, Lim CS, Abel ED. Mossalam M, et al. Among authors: lim cs. PLoS One. 2013;8(1):e53272. doi: 10.1371/journal.pone.0053272. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23341934 Free PMC article.

2

Controlling subcellular delivery to optimize therapeutic effect.

Mossalam M, Dixon AS, Lim CS. Mossalam M, et al. Among authors: lim cs. Ther Deliv. 2010 Jul;1(1):169-93. doi: 10.4155/tde.10.8. Ther Deliv. 2010. PMID: 21113240 Free PMC article. Review.

3

Direct induction of apoptosis using an optimal mitochondrially targeted p53.

Mossalam M, Matissek KJ, Okal A, Constance JE, Lim CS. Mossalam M, et al. Among authors: lim cs. Mol Pharm. 2012 May 7;9(5):1449-58. doi: 10.1021/mp3000259. Epub 2012 Mar 28. Mol Pharm. 2012. PMID: 22380534 Free PMC article.

4

Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction.

Davis JR, Mossalam M, Lim CS. Davis JR, et al. Among authors: lim cs. Pharm Res. 2012 Dec;29(12):3455-63. doi: 10.1007/s11095-012-0840-3. Epub 2012 Aug 7. Pharm Res. 2012. PMID: 22869106 Free PMC article.

5

Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib.

Constance JE, Woessner DW, Matissek KJ, Mossalam M, Lim CS. Constance JE, et al. Among authors: lim cs. Mol Pharm. 2012 Nov 5;9(11):3318-29. doi: 10.1021/mp3003539. Epub 2012 Oct 12. Mol Pharm. 2012. PMID: 22957899 Free PMC article.

6

Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.

Davis JR, Mossalam M, Lim CS. Davis JR, et al. Among authors: lim cs. Mol Pharm. 2013 Apr 1;10(4):1340-9. doi: 10.1021/mp300543t. Epub 2013 Mar 1. Mol Pharm. 2013. PMID: 23398638 Free PMC article.

7

A single mutant, A276S of p53, turns the switch to apoptosis.

Reaz S, Mossalam M, Okal A, Lim CS. Reaz S, et al. Among authors: lim cs. Mol Pharm. 2013 Apr 1;10(4):1350-9. doi: 10.1021/mp300598k. Epub 2013 Mar 1. Mol Pharm. 2013. PMID: 23402381 Free PMC article.

8

A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.

Okal A, Mossalam M, Matissek KJ, Dixon AS, Moos PJ, Lim CS. Okal A, et al. Among authors: lim cs. Mol Pharm. 2013 Oct 7;10(10):3922-33. doi: 10.1021/mp400379c. Epub 2013 Sep 9. Mol Pharm. 2013. PMID: 23964676 Free PMC article.

9

The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria.

Matissek KJ, Mossalam M, Okal A, Lim CS. Matissek KJ, et al. Among authors: lim cs. Mol Pharm. 2013 Oct 7;10(10):3592-602. doi: 10.1021/mp400380s. Epub 2013 Sep 6. Mol Pharm. 2013. PMID: 23968395 Free PMC article.

10

Delivery of a monomeric p53 subdomain with mitochondrial targeting signals from pro-apoptotic Bak or Bax.

Matissek KJ, Okal A, Mossalam M, Lim CS. Matissek KJ, et al. Among authors: lim cs. Pharm Res. 2014 Sep;31(9):2503-15. doi: 10.1007/s11095-014-1346-y. Epub 2014 Mar 15. Pharm Res. 2014. PMID: 24633417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,289 results

Search Page

Filters